Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jürgen Zapf
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Procedures
Anatomy
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
42
Froesch, ER
39
Schmid, Christoph
13
Gosteli-Peter, Martina
9
Zwimpfer, Cornelia
8
Wiesli, Peter
7
Reinecke, Manfred
7
Donath, Marc
6
Brändle, Michael
5
Zoidis, Evangelos
4
Eppler, Elisabeth
4
Hussain, Mehboob
4
Ghirlanda-Keller, Claudia
3
Hauri, C
3
Meinel, Lorenz
2
Gander, Bruno
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jürgen Zapf (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2007: Eppler Elisabeth; Caelers Antje; Shved Natallia; Hwang Guylin; Rahman Azizur M; Maclean Norman; Zapf Jürgen; Reinecke Manfred
Insulin-like growth factor I (IGF-I) in a growth-enhanced transgenic (GH-overexpressing) bony fish, the tilapia (Oreochromis niloticus): indication for a higher impact of autocrine/paracrine than of endocrine IGF-I.
Transgenic research 2007;16(4):479-89.
-
2007: Nauck Michael A; Reinecke Manfred; Perren Aurel; Frystyk Jan; Berishvili Giorgi; Zwimpfer Cornelia; Figge Anja M; Flyvbjerg Allan; Lankisch Paul G; Blum Werner F; Klöppel Günter; Schmiegel Wolff; Zapf Jürgen
Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung.
The Journal of clinical endocrinology and metabolism 2007;92(5):1600-5.
-
2006: Schmid Christoph; Zwimpfer Cornelia; Brändle Michael; Krayenbühl Pierre-Alexandre; Zapf Jürgen; Wiesli Peter
Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
Clinical endocrinology 2006;65(6):706-11.
-
2006: Wiesli Peter; Zwimpfer Cornelia; Zapf Jürgen; Schmid Christoph
Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
Acta obstetricia et gynecologica Scandinavica 2006;85(8):900-5.
-
2005: Schmid Christoph; Bianda Tarcisio; Zwimpfer Cornelia; Zapf Jürgen; Wiesli Peter
Changes in insulin sensitivity induced by short-term growth hormone (GH) and insulin-like growth factor I (IGF-I) treatment in GH-deficient adults are not associated with changes in adiponectin levels.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2005;15(4):300-3.
-
2005: Jevdjovic Tanja; Maake Caroline; Zwimpfer Cornelia; Krey Gunthild; Eppler Elisabeth; Zapf Jürgen; Reinecke Manfred
The effect of hypophysectomy on pancreatic islet hormone and insulin-like growth factor I content and mRNA expression in rat.
Histochemistry and cell biology 2005;123(2):179-88.
-
2005: Wiesli Peter; Bernays René; Brändle Michael; Zwimpfer Cornelia; Seiler Heidi; Zapf Jürgen; A Spinas Giatgen; Schmid Christoph
Effect of pituitary surgery in patients with acromegaly on adiponectin serum concentrations and alanine aminotransferase activity.
Clinica chimica acta; international journal of clinical chemistry 2005;352(1-2):175-81.
-
2004: Jevdjovic T; Maake C; Eppler E; Zoidis E; Reinecke M; Zapf J
Effects of insulin--like growth factor-I treatment on the endocrine pancreas of hypophysectomized rats: comparison with growth hormone replacement.
European journal of endocrinology / European Federation of Endocrine Societies 2004;151(2):223-31.
-
2004: Wiesli Peter; Brändle Michael; Pfammatter Thomas; Zapf Jürgen; Spinas Giatgen A; Schmid Christoph
Insulin determination by specific and unspecific immunoassays in patients with insulinoma evaluated by the arterial stimulation and venous sampling test.
European journal of endocrinology / European Federation of Endocrine Societies 2004;151(1):123-6.
-
2004: Zoidis E; Ghirlanda-Keller C; Gosteli-Peter M; Zapf J; Schmid C
Regulation of phosphate (Pi) transport and NaPi-III transporter (Pit-1) mRNA in rat osteoblasts.
The Journal of endocrinology 2004;181(3):531-40.
-
2004: Wiesli Peter; Brändle Michael; Zapf Jürgen; Seiler Heidi; Zwimpfer Cornelia; Spinas Giatgen A; Schmid Christoph
Assessment of hyperinsulinaemia at the termination of the prolonged fast.
Clinica chimica acta; international journal of clinical chemistry 2004;342(1-2):227-31.
-
2004: Schmid Christoph; Wiesli Peter; Bernays René; Bloch Konrad; Zapf Jürgen; Zwimpfer Cornelia; Ghirlanda Claudia; Brändle Michael
Decrease in sE-selectin after pituitary surgery in patients with acromegaly.
Clinical chemistry 2004;50(3):650-2.
-
2004: Schmid Christoph; Brändle Michael; Zwimpfer Cornelia; Zapf Jürgen; Wiesli Peter
Effect of thyroxine replacement on creatinine, insulin-like growth factor 1, acid-labile subunit, and vascular endothelial growth factor.
Clinical chemistry 2004;50(1):228-31.
-
2003: Meinel Lorenz; Zoidis Evangelos; Zapf Jürgen; Hassa Paulo; Hottiger Michael O; Auer Jörg A; Schneider Rebecca; Gander Bruno; Luginbuehl Vera; Bettschart-Wolfisberger Regula; Illi Oscar E; Merkle Hans P; von Rechenberg Brigitte
Localized insulin-like growth factor I delivery to enhance new bone formation.
Bone 2003;33(4):660-72.
-
2002: Zapf Jürgen; Gosteli-Peter Martina; Weckbecker Gisbert; Hunziker Ernst B; Reinecke Manfred
The somatostatin analog octreotide inhibits GH-stimulated, but not IGF-I-stimulated, bone growth in hypophysectomized rats.
Endocrinology 2002;143(8):2944-52.
-
2002: Eppler E; Zapf J; Bailer N; Falkmer U G; Falkmer S; Reinecke M
IGF-I in human breast cancer: low differentiation stage is associated with decreased IGF-I content.
European journal of endocrinology / European Federation of Endocrine Societies 2002;146(6):813-21.
-
2002: Zoidis Evangelos; Gosteli-Peter Martina; Ghirlanda-Keller Claudia; Meinel Lorenz; Zapf Jürgen; Schmid Christoph
IGF-I and GH stimulate Phex mRNA expression in lungs and bones and 1,25-dihydroxyvitamin D(3) production in hypophysectomized rats.
European journal of endocrinology / European Federation of Endocrine Societies 2002;146(1):97-105.
-
2001: Bostedt K T; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter K H; Zapf J
Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
Experimental cell research 2001;271(2):368-77.
-
2001: Schmid C; Ghirlanda-Keller C; Zapf J
Effects of IGF-I and -II, IGF binding protein-3 (IGFBP-3), and transforming growth factor-beta (TGF-beta) on growth and apoptosis of human osteosarcoma Saos-2/B-10 cells: lack of IGF-independent IGFBP-3 effects.
European journal of endocrinology / European Federation of Endocrine Societies 2001;145(2):213-21.
-
2001: Meinel L; Illi O E; Zapf J; Malfanti M; Peter Merkle H; Gander B
Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres.
Journal of controlled release : official journal of the Controlled Release Society 2001;70(1-2):193-202.
-
2000: Zoidis E; Zapf J; Schmid C
Phex cDNA cloning from rat bone and studies on phex mRNA expression: tissue-specificity, age-dependency, and regulation by insulin-like growth factor (IGF) I in vivo.
Molecular and cellular endocrinology 2000;168(1-2):41-51.
-
2000: Reinecke M; Schmid A C; Heyberger-Meyer B; Hunziker E B; Zapf J
Effect of growth hormone and insulin-like growth factor I (IGF-I) on the expression of IGF-I messenger ribonucleic acid and peptide in rat tibial growth plate and articular chondrocytes in vivo.
Endocrinology 2000;141(8):2847-53.
-
2000: Zapf J; Donath M Y; Schmid C
[Spectrum of effectiveness of insulin-like growth factors (IGF)]
Schweizerische medizinische Wochenschrift 2000;130(6):190-5.
-
1999: Donath M Y; Zapf J
Insulin-like growth factor I: an attractive option for chronic heart failure?
Drugs & aging 1999;15(4):251-4.
-
1999: Schmid C; Keller C; Gosteli-Peter M; Zapf J
Mitogenic and antiapoptotic effects of insulin-like growth factor binding protein-6 in the human osteoblastic osteosarcoma cell line Saos-2/B-10.
Biochemical and biophysical research communications 1999;263(3):786-9.
-
1999: Bianda T; Zapf J; Froesch E R; Schmid C
Insulin-like growth factor-I lowers fasting and postprandial triglyceride levels without affecting chylomicron clearance in healthy men.
Journal of internal medicine 1999;245(5):455-62.
-
1999: Böni-Schnetzler M; Hauri C; Zapf J
Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats.
Diabetologia 1999;42(2):160-6.
-
1998: Donath M Y; Sütsch G; Yan X W; Piva B; Brunner H P; Glatz Y; Zapf J; Follath F; Froesch E R; Kiowski W
Acute cardiovascular effects of insulin-like growth factor I in patients with chronic heart failure.
The Journal of clinical endocrinology and metabolism 1998;83(9):3177-83.
-
1998: Donath M Y; Zierhut W; Gosteli-Peter M A; Hauri C; Froesch E R; Zapf J
Effects of IGF-I on cardiac growth and expression of mRNAs coding for cardiac proteins after induction of heart hypertrophy in the rat.
European journal of endocrinology / European Federation of Endocrine Societies 1998;139(1):109-17.
-
1998: Zapf J
Growth promotion by insulin-like growth factor I in hypophysectomized and diabetic rats.
Molecular and cellular endocrinology 1998;140(1-2):143-9.
-
1998: Donath M Y; Froesch E R; Zapf J
Insulin-like growth factor I and cardiac performance in heart failure.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1998;8 Suppl B():167-70.
-
1998: Schmid C; Keller C; Schläpfer I; Veldman C; Zapf J
Calcium and insulin-like growth factor I stimulation of sodium-dependent phosphate transport and proliferation of cultured rat osteoblasts.
Biochemical and biophysical research communications 1998;245(1):220-5.
-
1997: Schmitt S; Ren-Qiu Q; Torresani T; Doebeli M; Zapf J; Schoenle E J
High molecular weight forms of IGF-II ('big-IGF-II') released by Wilms' tumor cells.
European journal of endocrinology / European Federation of Endocrine Societies 1997;137(4):396-401.
-
1997: Donath M Y; Gosteli-Peter M A; Hauri C; Froesch E R; Zapf J
Insulin-like growth factor-I stimulates myofibrillar genes and modulates atrial natriuretic factor mRNA in rat heart.
European journal of endocrinology / European Federation of Endocrine Societies 1997;137(3):309-15.
-
1997: Zapf J
Total and free IGF serum levels.
European journal of endocrinology / European Federation of Endocrine Societies 1997;136(2):146-7.
-
1996: Schmid C; Schläpfer I; Gosteli-Peter M A; Froesch E R; Zapf J
Effects and fate of human IGF-binding protein-5 in rat osteoblast cultures.
The American journal of physiology 1996;271(6 Pt 1):E1029-35.
-
1996: Froesch E R; Hussain M A; Schmid C; Zapf J
Insulin-like growth factor I: physiology, metabolic effects and clinical uses.
Diabetes/metabolism reviews 1996;12(3):195-215.
-
1996: Gosteli-Peter M A; Harder B A; Eppenberger H M; Zapf J; Schaub M C
Triiodothyronine induces over-expression of alpha-smooth muscle actin, restricts myofibrillar expansion and is permissive for the action of basic fibroblast growth factor and insulin-like growth factor I in adult rat cardiomyocytes.
The Journal of clinical investigation 1996;98(8):1737-44.
-
1996: Schmid C; Schläpfer I; Gosteli-Peter M A; Hauri C; Froesch E R; Zapf J
1 alpha,25-dihydroxyvitamin D3 increases IGF binding protein-5 expression in cultured osteoblasts.
FEBS letters 1996;392(1):21-4.
-
1996: Böni-Schnetzler M; Gosteli-Peter M A; Moritz W; Froesch E R; Zapf J
Reduced ob mRNA in hypophysectomised rats is not restored by growth hormone (GH), but further suppressed by exogenously administered insulin-like growth factor (IGF) I.
Biochemical and biophysical research communications 1996;225(1):296-301.
-
1996: Gosteli-Peter M A; Schmid C; Zapf J
Triiodothyronine increases glucose transporter isotype 4 mRNA expression, glucose transport, and glycogen synthesis in adult rat cardiomyocytes in long-term culture.
Biochemical and biophysical research communications 1996;221(3):521-4.
-
1995: Schmid C; Schläpfer I; Keller A; Waldvogel M; Froesch E R; Zapf J
Effects of insulin-like growth factor (IGF) binding proteins (BPs) -3 and -6 on DNA synthesis of rat osteoblasts: further evidence for a role of auto-/paracrine IGF I but not IGF II in stimulating osteoblast growth.
Biochemical and biophysical research communications 1995;212(1):242-8.
-
1995: Zapf J
Physiological role of the insulin-like growth factor binding proteins.
European journal of endocrinology / European Federation of Endocrine Societies 1995;132(6):645-54.
-
1995: Conover C A; Durham S K; Zapf J; Masiarz F R; Kiefer M C
Cleavage analysis of insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis and expression of protease-resistant IGF-binding protein-4 mutants.
The Journal of biological chemistry 1995;270(9):4395-400.
-
1995: Zapf J; Hauri C; Futo E; Hussain M; Rutishauser J; Maack C A; Froesch E R
Intravenously injected insulin-like growth factor (IGF) I/IGF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats.
The Journal of clinical investigation 1995;95(1):179-86.
-
1995: Schmid C; Schläpfer I; Gosteli-Peter M A; Froesch E R; Zapf J
Expression, effects, and fate of IGFBP-5 are different in normal and malignant osteoblastic cells.
Progress in growth factor research 1995;6(2-4):167-73.
-
1994: Gosteli-Peter M A; Winterhalter K H; Schmid C; Froesch E R; Zapf J
Expression and regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with IGF-I and growth hormone.
Endocrinology 1994;135(6):2558-67.
-
1994: Hussain M A; Schmitz O; Mengel A; Glatz Y; Christiansen J S; Zapf J; Froesch E R
Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.
The Journal of clinical investigation 1994;94(3):1126-33.
-
1994: Schmid C; Schläpfer I; Peter M; Böni-Schnetzler M; Schwander J; Zapf J; Froesch E R
Growth hormone and parathyroid hormone stimulate IGFBP-3 in rat osteoblasts.
The American journal of physiology 1994;267(2 Pt 1):E226-33.
-
1994: Donath M Y; Zapf J; Eppenberger-Eberhardt M; Froesch E R; Eppenberger H M
Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle alpha-actin of adult cardiomyocytes.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(5):1686-90.
-
1994: Zapf J
Role of insulin-like growth factor II and IGF binding proteins in extrapancreatic tumor hypoglycemia.
Hormone research 1994;42(1-2):20-6.
-
1993: Peter M A; Winterhalter K H; Böni-Schnetzler M; Froesch E R; Zapf J
Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by growth hormone in rat white adipose tissue.
Endocrinology 1993;133(6):2624-31.
-
1993: Zapf J
Role of insulin-like growth factor (IGF) II and IGF binding proteins in extrapancreatic tumour hypoglycaemia.
Journal of internal medicine 1993;234(6):543-52.
-
1993: Hussain M A; Schmitz O; Mengel A; Keller A; Christiansen J S; Zapf J; Froesch E R
Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans.
The Journal of clinical investigation 1993;92(5):2249-56.
-
1993: Rutishauser J; Schmid C; Hauri C; Froesch E R; Zapf J
Growth hormone, but not insulin-like growth factor I, induces a serum protease activity for insulin-like growth factor binding protein-3 in hypophysectomized rats in vivo.
FEBS letters 1993;334(1):23-6.
-
1993: Eriksson U; Duc G; Froesch E R; Zapf J
Insulin-like growth factors (IGF) I and II and IGF binding proteins (IGFBPs) in human colostrum/transitory milk during the first week postpartum: comparison with neonatal and maternal serum.
Biochemical and biophysical research communications 1993;196(1):267-73.
-
1993: Schmid C; Schläpfer I; Waldvogel M; Peter M; Zapf J; Froesch E R
Production of IGFBP-3 by connective tissue and endothelial cells.
Growth regulation 1993;3(1):65-7.
-
1993: Kiefer M C; Schmid C; Waldvogel M; Schläpfer I; Futo E; Masiarz F R; Green K; Barr P J; Zapf J
Recombinant human insulin-like growth factor binding proteins 4, 5, and 6: biological and physiochemical characterization.
Growth regulation 1993;3(1):56-9.
-
1993: Conover C A; Kiefer M C; Zapf J
Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies.
The Journal of clinical investigation 1993;91(3):1129-37.
-
1992: Zapf J; Futo E; Peter M; Froesch E R
Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?
The Journal of clinical investigation 1992;90(6):2574-84.
-
1992: Schmid C; Schläpfer I; Waldvogel M; Zapf J; Froesch E R
Prostaglandin E2 stimulates synthesis of insulin-like growth factor binding protein-3 in rat bone cells in vitro.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1992;7(10):1157-63.
-
1992: Kiefer M C; Schmid C; Waldvogel M; Schläpfer I; Futo E; Masiarz F R; Green K; Barr P J; Zapf J
Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast.
The Journal of biological chemistry 1992;267(18):12692-9.
-
1992: Schmid C; Schläpfer I; Waldvogel M; Meier P J; Schwander J; Böni-Schnetzler M; Zapf J; Froesch E R
Differential regulation of insulin-like growth factor binding protein (IGFBP)-2 mRNA in liver and bone cells by insulin and retinoic acid in vitro.
FEBS letters 1992;303(2-3):205-9.
-
1992: Schmid C; Schläpfer I; Futo E; Waldvogel M; Schwander J; Zapf J; Froesch E R
Triiodothyronine (T3) stimulates insulin-like growth factor (IGF)-1 and IGF binding protein (IGFBP)-2 production by rat osteoblasts in vitro.
Acta endocrinologica 1992;126(5):467-73.
-
1991: Schmid C; Rutishauser J; Schläpfer I; Froesch E R; Zapf J
Intact but not truncated insulin-like growth factor binding protein-3 (IGFBP-3) blocks IGF I-induced stimulation of osteoblasts: control of IGF signalling to bone cells by IGFBP-3-specific proteolysis?
Biochemical and biophysical research communications 1991;179(1):579-85.
-
1991: Kiefer M C; Masiarz F R; Bauer D M; Zapf J
Identification and molecular cloning of two new 30-kDa insulin-like growth factor binding proteins isolated from adult human serum.
The Journal of biological chemistry 1991;266(14):9043-9.
-
1991: Kiefer M C; Ioh R S; Bauer D M; Zapf J
Molecular cloning of a new human insulin-like growth factor binding protein.
Biochemical and biophysical research communications 1991;176(1):219-25.
-
1991: Guler H P; Wettstein K; Schurr W; Zapf J; Froesch E R
Recombinant human insulin-like growth factor I: effects in normal subjects and implications for use in patients.
Advances in experimental medicine and biology 1991;293():97-104.
-
1990: Böni-Schnetzler M; Schmid C; Mary J L; Zimmerli B; Meier P J; Zapf J; Schwander J; Froesch E R
Insulin regulates the expression of the insulin-like growth factor binding protein 2 mRNA in rat hepatocytes.
Molecular endocrinology (Baltimore, Md.) 1990;4(9):1320-6.
-
1990: Zapf J; Schmid C; Guler H P; Waldvogel M; Hauri C; Futo E; Hossenlopp P; Binoux M; Froesch E R
Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia.
The Journal of clinical investigation 1990;86(3):952-61.
-
1990: Zapf J; Kiefer M; Merryweather J; Musiarz F; Bauer D; Born W; Fischer J A; Froesch E R
Isolation from adult human serum of four insulin-like growth factor (IGF) binding proteins and molecular cloning of one of them that is increased by IGF I administration and in extrapancreatic tumor hypoglycemia.
The Journal of biological chemistry 1990;265(25):14892-8.
-
1990: Binz K; Joller P; Froesch P; Binz H; Zapf J; Froesch E R
Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(10):3690-4.
-
1990: Guler H P; Schmid C; Zapf J; Froesch E R
Effects of insulin-like growth factor I in man.
Acta paediatrica Scandinavica. Supplement 1990;367():52-4.
-
1989: Keller S; Zapf J
Effect of insulin on glucose transporter distribution in white fat cells from hypophysectomized rats.
FEBS letters 1989;259(1):189-93.
-
1989: Guler H P; Zapf J; Schmid C; Froesch E R
Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates.
Acta endocrinologica 1989;121(6):753-8.
-
1989: Binz K; Zapf J; Froesch E R
The role of insulin-like growth factor I in growth of diabetic rats.
Acta endocrinologica 1989;121(5):628-32.
-
1989: Guler H P; Binz K; Eigenmann E; Jäggi S; Zimmermann D; Zapf J; Froesch E R
Small stature and insulin-like growth factors: prolonged treatment of mini-poodles with recombinant human insulin-like growth factor I.
Acta endocrinologica 1989;121(3):456-64.
-
1989: Keller S; Schmid C; Zapf J; Froesch E R
Inhibition of insulin degradation by insulin-like growth factors I and II in human hepatoma (HepG2) cells.
Acta endocrinologica 1989;121(2):279-85.
-
1989: Zapf J; Hauri C; Waldvogel M; Futo E; Häsler H; Binz K; Guler H P; Schmid C; Froesch E R
Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(10):3813-7.
-
1989: Guler H P; Schmid C; Zapf J; Froesch E R
Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(8):2868-72.
-
1988: Zapf J; Born W; Chang J Y; James P; Froesch E R; Fischer J A
Isolation and NH2-terminal amino acid sequences of rat serum carrier proteins for insulin-like growth factors.
Biochemical and biophysical research communications 1988;156(3):1187-94.
-
1988: Guler H P; Zapf J; Scheiwiller E; Froesch E R
Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(13):4889-93.
-
1988: Zenobi P D; Guler H P; Zapf J; Froesch E R
Insulin-like growth factors in the Göttinger miniature-pig.
Acta endocrinologica 1988;117(3):343-52.
-
1986: Zapf J; Hauri C; Waldvogel M; Froesch E R
Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats.
The Journal of clinical investigation 1986;77(6):1768-75.
Sign-in to see more
